A detailed history of Aviva PLC transactions in Danaher Corp stock. As of the latest transaction made, Aviva PLC holds 792,681 shares of DHR stock, worth $182 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
792,681
Previous 752,921 5.28%
Holding current value
$182 Million
Previous $188 Million 17.14%
% of portfolio
0.6%
Previous 0.55%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $9.51 Million - $11.2 Million
39,760 Added 5.28%
792,681 $220 Million
Q2 2024

Aug 02, 2024

BUY
$235.51 - $267.98 $19.3 Million - $21.9 Million
81,890 Added 12.2%
752,921 $188 Million
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $1.29 Million - $1.47 Million
-5,727 Reduced 0.85%
671,031 $168 Million
Q4 2023

Feb 09, 2024

BUY
$185.1 - $233.13 $14.4 Million - $18.1 Million
77,790 Added 12.99%
676,758 $157 Million
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $18.8 Million - $21.5 Million
80,831 Added 15.6%
598,968 $149 Million
Q2 2023

Aug 10, 2023

BUY
$224.99 - $256.14 $53.1 Million - $60.5 Million
236,104 Added 83.72%
518,137 $124 Million
Q1 2023

May 12, 2023

BUY
$239.75 - $277.0 $5.57 Million - $6.43 Million
23,214 Added 8.97%
282,033 $71.1 Million
Q4 2022

Feb 09, 2023

BUY
$241.42 - $282.29 $15.6 Million - $18.2 Million
64,629 Added 33.28%
258,819 $68.7 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $5.11 Million - $31.2 Million
20,666 Added 11.91%
194,190 $50.2 Million
Q2 2022

Aug 04, 2022

BUY
$237.11 - $299.66 $714,886 - $903,474
3,015 Added 1.77%
173,524 $44 Million
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $6.87 Million - $8.43 Million
-26,695 Reduced 13.54%
170,509 $50 Million
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $931,151 - $1.05 Million
3,188 Added 1.64%
197,204 $64.9 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $2.64 Million - $3.23 Million
-9,715 Reduced 4.77%
194,016 $59.1 Million
Q2 2021

Aug 10, 2021

SELL
$225.08 - $271.69 $1.13 Million - $1.36 Million
-5,003 Reduced 2.4%
203,731 $54.7 Million
Q1 2021

May 13, 2021

BUY
$212.38 - $245.9 $221,087 - $255,981
1,041 Added 0.5%
208,734 $47 Million
Q4 2020

Feb 10, 2021

BUY
$212.5 - $245.46 $1.16 Million - $1.34 Million
5,474 Added 2.71%
207,693 $46.1 Million
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $1.16 Million - $1.41 Million
-6,558 Reduced 3.14%
202,219 $43.5 Million
Q2 2020

Aug 13, 2020

SELL
$128.7 - $176.83 $4.46 Million - $6.13 Million
-34,643 Reduced 14.23%
208,777 $36.9 Million
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $41.7 Million - $58 Million
-343,185 Reduced 58.5%
243,420 $33.7 Million
Q4 2019

Feb 10, 2020

SELL
$133.47 - $153.48 $2.79 Million - $3.21 Million
-20,905 Reduced 3.44%
586,605 $90 Million
Q3 2019

Nov 12, 2019

SELL
$135.4 - $146.47 $1.35 Million - $1.46 Million
-9,966 Reduced 1.61%
607,510 $87.7 Million
Q2 2019

Jul 30, 2019

SELL
$124.88 - $143.73 $16.3 Million - $18.7 Million
-130,186 Reduced 17.41%
617,476 $88.3 Million
Q1 2019

May 14, 2019

BUY
$97.62 - $132.29 $273,043 - $370,015
2,797 Added 0.38%
747,662 $98.7 Million
Q4 2018

Feb 12, 2019

SELL
$94.85 - $109.54 $2.07 Million - $2.39 Million
-21,781 Reduced 2.84%
744,865 $76.8 Million
Q3 2018

Nov 13, 2018

BUY
$98.13 - $108.9 $638,531 - $708,612
6,507 Added 0.86%
766,646 $83.3 Million
Q2 2018

Aug 01, 2018

SELL
$96.1 - $103.24 $2.45 Million - $2.63 Million
-25,510 Reduced 3.25%
760,139 $75 Million
Q1 2018

May 14, 2018

BUY
$92.16 - $103.8 $34.2 Million - $38.6 Million
371,585 Added 89.74%
785,649 $76.9 Million
Q4 2017

Feb 13, 2018

BUY
$85.26 - $94.62 $2.36 Million - $2.62 Million
27,729 Added 7.18%
414,064 $38.4 Million
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $586,746 - $654,530
7,400 Added 1.95%
386,335 $33.1 Million
Q2 2017

Aug 07, 2017

BUY
N/A
378,935
378,935 $32 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.